Back to Search
Start Over
Imaging of Gastrointestinal Stromal Tumors and Assessment of Benefit from Systemic Therapy
- Source :
- Hematology/Oncology Clinics of North America. 23:35-48
- Publication Year :
- 2009
- Publisher :
- Elsevier BV, 2009.
-
Abstract
- While gastrointestinal stromal tumors have been increasingly recognized with the prolonged survival and highly effective new targeted treatments, the role of imaging has become important not only for diagnosing and staging the tumors, but also for monitoring the effects of treatment and surveillance. Computed tomography is the imaging modality of choice for these purposes. Fluorine-18 fluorodeoxyglucose positron emission tomography is primarily used in problem solving when there are inconsistencies between CT and clinical findings or inconclusive CT images. The roles of MRI and ultrasound are also described.
- Subjects :
- Diagnostic Imaging
medicine.medical_specialty
Modality (human–computer interaction)
Stromal cell
medicine.diagnostic_test
Gastrointestinal Stromal Tumors
business.industry
Ultrasound
Computed tomography
Hematology
Magnetic Resonance Imaging
Systemic therapy
Fluorodeoxyglucose positron emission tomography
Oncology
Positron-Emission Tomography
medicine
Humans
Radiology
Neoplasm Metastasis
Neoplasm Recurrence, Local
Tomography, X-Ray Computed
business
Subjects
Details
- ISSN :
- 08898588
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Hematology/Oncology Clinics of North America
- Accession number :
- edsair.doi.dedup.....1e0beab2f630f0a056dc193a80ab7ade